powered by
▸
healthparse
Search
Cohort Builder
Tools
▾
KOL Finder
Territories
Drug Compare
AI Query
Research
Browse
▾
By state
By specialty
Pricing
Search
Cohort Builder
Tools
KOL Finder
Territories
Drug Compare
AI Query
Research
Browse
By state
By specialty
Pricing
PROVIDER PROFILE · NPI 1982018933
Christopher Barnes
D.O.
Endocrinology
Elmira,
NY
I
CROSS-REFERENCE
Related data on other Healthparse brands
ProviderScore
OIG/SAM exclusion screening, sanctions history
Healthparse Signals
Monitor this provider for changes — dated NPI change events
QUALITY · MIPS · 2024
Final MIPS score
80.2
Quality
46.8
Cost
77.1
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.22%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$50
Payment records
2
By payment type
Food and Beverage
$50
Top paying entities
Food and Beverage
$50
PRESCRIBING · PART D · 2024
Total Rx claims
7,596
Beneficiaries
—
Total drug cost
$3.6M
Distinct drugs
64
Brand share
59.6%
Top prescribed drugs
Levothyroxine Sodium
1,166 claims
Semaglutide
831 claims
Empagliflozin
458 claims
Insulin Glargine,hum.Rec.Anlog
352 claims
Metformin Hcl
333 claims
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
442
Unique beneficiaries
—
Total services
817
Distinct HCPCS
3
Medicare payment
$53K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 627 Endocrinology providers in NY — above median (cohort median 837).
